OBiO Technology unveiled to construct new state-of-the-art GMP production facility, Intelli-M. for developing advanced therapies in Shanghai, China.
The Intelli-M facility covers an area of 828,000 square feet and is equipped with 29 production lines. It consists of a variety of single-use bioreactors ranging in size from 50 to 2000 litres and features closed downstream processing, allowing for flexibility.
The facility is well-equipped with advanced technologies to support the pharmaceutical and biotechnology sectors.
The site plays a pivotal role in enhancing production and service capabilities in both China and the United States. It covers activities from the proof of concept and investigational new drug (IND) declaration stages to new drug application and commercial manufacturing.
The new production facility will offer comprehensive services worldwide, catering to the increasing demand for contract development and manufacturing organisation (CDMO) solutions in the field of gene therapy accelerating the pace of innovation in the pharmaceutical industry.
Name OBiO Technology
Type New Construction